Narcolepsy Type 1

SILVER SPRING, Maryland & RESEARCH TRIANGLE PARK, North Carolina, Aug 28, 2026 United Therapeutics Corporation announced that new clinical...

OSAKA, Japan & CAMBRIDGE, Massachusetts, Aug 24, 2026 Takeda Pharmaceutical Company Limited announced that Japan’s Ministry of Health, Labour...

DUBLIN, August 24, 2026 Alkermes plc announced the publication of positive Vibrance-1 Phase 2 results for alixorexton in The...

OSAKA, Japan and CAMBRIDGE, Massachusetts, June 15, 2026 Takeda has unveiled new pivotal Phase 3 data demonstrating that oveporexton...